Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019
April 22, 2019 at 11:01 pm IST
Share
Jiangxi Synergy Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was CNY 81.778 million compared to CNY 71.772 million a year ago. Operating income was CNY 4.473 million compared to CNY 6.994 million a year ago. Net income was CNY 4.470 million compared to CNY 6.074 million a year ago. Basic earnings per share from continuing operations was CNY 0.0556 compared to CNY 0.0759 a year ago. Diluted earnings per share from continuing operations was CNY 0.0556 compared to CNY 0.0747 a year ago.
Jiangxi Synergy Pharmaceutical Co Ltd is a pharmaceutical manufacturing company. The Company is engaged in research, development, production and sales of chemical raw materials and pharmaceutical intermediates. The Company's products are used in various types of drugs, including nervous system drugs, such as antiepileptic drugs and antiulcer drugs; non-steroidal anti-inflammatory analgesics; circulatory system drugs, such as antihypertensive drugs; mental disorders drugs, such as antidepressants Medicine; and anti-viral drugs. The company's products are sold to domestic and foreign markets, including Europe, North America and Japan.
JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. 
